BMS-986259

DRUG3 trials

Sponsors

Bristol-Myers Squibb

Conditions

Acute Decompensated Heart FailureHealthy ParticipantsRenal Failure

Phase 1

An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants

CompletedNCT04008992

Bristol-Myers SquibbHealthy Participants

Start: 2019-06-18End: 2021-01-04Updated: 2021-04-09

A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 in Participants With Various Levels of Kidney Function

CompletedNCT04237831

Bristol-Myers SquibbRenal Failure

Start: 2020-02-26End: 2021-07-16Updated: 2021-09-24

Phase 2

Study of the Safety of BMS-986259 in Participants With Post-Acute Decompensated Heart Failure

CompletedNCT04318093

Bristol-Myers SquibbAcute Decompensated Heart Failure

Start: 2020-11-06End: 2021-07-19Updated: 2022-08-04